Moneycontrol
    Moneycontrol PRO

    Jump to

    • Buy Strides Pharma Sciences; target of Rs 1874: Sharekhan

      Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 1874 in its research report dated October 24, 2024.

    • Buy Strides Pharma Science; target of Rs 800: Sharekhan

      Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 800 in its research report dated January 30, 2024.

    • Accumulate Strides Pharma Science; target of Rs 731: Geojit

      Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 731 in its research report dated December 26, 2023.

    • Reduce Strides Pharma Science; target of Rs 495: ICICI Securities

      ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.

    • Hold Strides Pharma Science; target of Rs 600: Sharekhan

      Sharekhan recommended Hold rating on Strides Pharma Science with a target price of Rs 600 in its research report dated September 26, 2023.

    • Hold Strides Pharma Sciences; target of Rs 491: Sharekhan

      Sharekhan recommended Hold rating on Strides Pharma Sciences with a target price of Rs 491 in its research report dated August 02, 2023.

    • Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

    • Buy Strides Pharma Sciences, target of Rs 450: Sharekhan

    • Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

    • Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

    • Accumulate Strides Pharma Science; target of Rs 355: Geojit

    • Buy Strides Pharma Science; target of Rs 936: Geojit

    • Buy Strides Pharma; target of Rs 930: Motilal Oswal

    • What to buy after Sensex fall? 10 stocks to buy for next 3-4 weeks based on technicals

    • Buy Strides Pharma Science; target of Rs 1020: Sharekhan

    • Lupin: New launches and market share gains are likely to override pricing erosion

    • Buy Strides Pharma Sciences; target of Rs 864: Sharekhan

    • Buy Strides Pharma Science: target of Rs 710: ICICI Securities

    • Accumulate Strides Pharma Science; target of Rs 621: Geojit

    • Buy Strides Pharma; target of Rs 650: Motilal Oswal

    • Buy Strides Pharma Science; target of Rs 421: ICICI Securities

    • Market Headstart: Nifty likely to go lower towards 12,200 levels; ICICI Bank in focus

    • Ranitidine controversy: Which Indian pharma companies stand to lose?

    • Market Headstart: Nifty seen opening higher; Eicher, Ujjivan top buys

    • Ideas for Profit | An API company that combines good growth prospects with reasonable valuations

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347